PNC Financial Services Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.7K Sell
7,081
-1,586
-18% -$7.04K ﹤0.01% 3713
2026
Q2
$47K Buy
8,667
+2,626
+43% +$10.1K ﹤0.01% 3326
2026
Q1
$13.8K Buy
6,041
+3,967
+191% +$12.6K ﹤0.01% 3804
2025
Q4
$8.3K Buy
2,074
+1,762
+565% +$9.8K ﹤0.01% 4010
2025
Q3
$2.64K Sell
312
-152
-33% -$1.48K ﹤0.01% 4402
2025
Q2
$5.22K Buy
464
+161
+53% +$1.48K ﹤0.01% 4080
2025
Q1
$2.87K Sell
303
-112
-27% -$1.13K ﹤0.01% 4235
2024
Q4
$4.67K Sell
415
-131
-24% -$2.3K ﹤0.01% 4042
2024
Q3
$15.4K Buy
546
+445
+441% +$11.5K ﹤0.01% 3587
2024
Q2
$1.93K Sell
101
-4,739
-98% -$121K ﹤0.01% 4246
2024
Q1
$159K Buy
4,840
+4,529
+1,456% +$145K ﹤0.01% 2204
2023
Q4
$10.3K Buy
311
+67
+27% +$1.9K ﹤0.01% 3675
2023
Q3
$6.64K Sell
244
-300
-55% -$8.34K ﹤0.01% 3877
2023
Q2
$16.5K Sell
544
-269
-33% -$8.7K ﹤0.01% 3573
2023
Q1
$26.4K Sell
813
-69
-8% -$2.18K ﹤0.01% 3291
2022
Q4
$24.8K Sell
882
-41
-4% -$1.18K ﹤0.01% 3309
2022
Q3
$34K Buy
923
+537
+139% +$18.9K ﹤0.01% 3128
2022
Q2
$12K Buy
386
+113
+41% +$3.29K ﹤0.01% 3672
2022
Q1
$9K Buy
273
+185
+210% +$4.84K ﹤0.01% 3812
2021
Q4
$3K Sell
88
-431
-83% -$12.4K ﹤0.01% 4046
2021
Q3
$16K Buy
519
+394
+315% +$9.46K ﹤0.01% 3547
2021
Q2
$3K Buy
125
+102
+443% +$2.04K ﹤0.01% 3955
2021
Q1
$0 Hold
23
– – ﹤0.01% 4134
2020
Q4
$0 Hold
23
– – ﹤0.01% 3991
2020
Q3
$0 Sell
23
-28
-55% – ﹤0.01% 3954
2020
Q2
$0 Sell
51
-5,796
-99% -$38.8K ﹤0.01% 3949
2020
Q1
$31K Hold
5,847
– – ﹤0.01% 2832
2019
Q4
$53K Hold
5,847
– – ﹤0.01% 2772
2019
Q3
$42K Buy
5,847
+23
+0.4% +$165 ﹤0.01% 2927
2019
Q2
$46K Sell
5,824
-4,350
-43% -$51.5K ﹤0.01% 2893
2019
Q1
$128K Sell
10,174
-3,704
-27% -$58.6K ﹤0.01% 2291
2018
Q4
$276K Buy
13,878
+4,350
+46% +$101K ﹤0.01% 1749
2018
Q3
$270K Buy
9,528
+2,448
+35% +$58.4K ﹤0.01% 1897
2018
Q2
$149K Buy
7,080
+918
+15% +$17.4K ﹤0.01% 2236
2018
Q1
$88K Sell
6,162
-8,078
-57% -$116K ﹤0.01% 2508
2017
Q4
$176K Buy
14,240
+4,570
+47% +$64.4K ﹤0.01% 2113
2017
Q3
$172K Hold
9,670
– – ﹤0.01% 2076
2017
Q2
$245K Buy
9,670
+6,670
+222% +$160K ﹤0.01% 1864
2017
Q1
$67K Hold
3,000
– – ﹤0.01% 2607
2016
Q4
$44K Buy
3,000
+1,000
+50% +$19.7K ﹤0.01% 2795
2016
Q3
$49K Hold
2,000
– – ﹤0.01% 2718
2016
Q2
$38K Hold
2,000
– – ﹤0.01% 2871
2016
Q1
$21K Hold
2,000
– – ﹤0.01% 3167
2015
Q4
$24K Hold
2,000
– – ﹤0.01% 3132
2015
Q3
$32K Buy
+2,000
New +$39K ﹤0.01% 3013

Other funds holding EVH

PNC Financial Services Group's EVH Position: Q3 2026 in Review

PNC Financial Services Group reduced its Evolent Health (EVH) stake by 18% in Q3 2026, selling an estimated $7.04K and leaving 7,081 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

PNC Financial Services Group first reported a position in EVH in Q3 2015 and has held it in 45 quarters since. The position peaked at $276K in Q4 2018. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • PNC Financial Services Group held 7,081 shares of Evolent Health worth $24.7K as of Q3 2026.
  • PNC Financial Services Group sold 1,586 Evolent Health shares in Q3 2026, an estimated $7.04K.
  • Evolent Health made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3713 holding.
  • PNC Financial Services Group first reported a position in Evolent Health in Q3 2015 and has held it in 45 quarters since.
  • PNC Financial Services Group's Evolent Health position peaked at $276K in Q4 2018.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.